M. Giráldez

发表

Substance use disorders in patients with intellectual disability admitted to psychiatric hospitalisation

J. Salavert, J. Borrás, A. Clarabuch, 2018, Journal of intellectual disability research : JIDR.

QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents.

C. Arango, M. Parellada, M. D. de Castro, 2008, Journal of child and adolescent psychopharmacology.

Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics.

C. Arango, M. Parellada, J. Merchán-Naranjo, 2008, The Journal of clinical psychiatry.

Plasma antioxidant capacity is reduced in Asperger syndrome.

J. Leza, C. Arango, M. Parellada, 2012, Journal of psychiatric research.

Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.

J. Alda, E. de la Serna, I. Baeza, 2010, Bipolar disorders.

Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics.

M. Desco, C. Arango, M. Parellada, 2011, Clinical nutrition.

Original Article Neurological soft signs in juvenile patients with Asperger syndrome, early-onset psychosis, and healthy controls

C. Arango, M. Parellada, J. Merchán-Naranjo, 2010 .

Neurological soft signs in juvenile patients with Asperger syndrome, early‐onset psychosis, and healthy controls

C. Arango, M. Parellada, J. Merchán-Naranjo, 2010, Early intervention in psychiatry.

Neurological soft signs in juvenile patients with Asperger syndrome , early-onset psychosis , and healthy controlseip

C. Arango, M. Parellada, J. Merchán-Naranjo, 2010 .

QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents.

C. Arango, M. Parellada, M. D. de Castro, 2008, Journal of child and adolescent psychopharmacology.